Melanoma accounts for 4% of all skin malignancies and 75% of all skin cancer deaths. Currently the 8th most common
malignancy in the United States, the incidence of melanoma has rapidly increased. Treatment of melanoma on the lower
extremity includes wide local excision and possible use of sentinel node biopsy evaluation. The aim of this article is to describe
the new AJCC?s new staging system for skin melanoma and present demographic, prognostic, and treatment data. A 10-year
retrospective review was conducted based on charts from a single surgeon practicing in a private plastic surgery office in a middle
class suburb of a large city. Charts were parsed for age at diagnosis, gender, location, Breslow depth, Clark?s level, and the presence
of ulceration, regression, and nodularity. We present a series of 35 patients and their interesting demographic data. The lower leg
was the most common site of involvement, and more than half of all lesions had a Breslow depth less than 0.5 mm. One patient
died of her disease in her 90s and another refused treatment. Melanoma of the lower extremity has had an evolution in both the
diagnosis and treatment of this disease.
Carl H. Manstein received his MD from Temple University in 1976 and his MBA from LaSalle University in 1998. He is the former President of the
Robert H. IVY Society of Plastic Surgeons.
Omar E. Beidas completed his MD from Temple University in Philadelphia, PA. He is currently a first-year plastic surgery resident at the University
of Oklahoma with an expected graduation date of June, 2017.
Mark E. Manstein graduated with his MD in 1978 from Medical College of Pennsylvania. He is currently Chief of Plastic Surgery at Holy Redeemer
Medical Center in Meadowbrook, PA.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals